Skip to content

Development and validation of a clinical model for predicting the risk of ST-segment elevation myocardial infarction in young and middle-aged populations

Development and validation of a clinical model for predicting the risk of ST-segment elevation myocardial infarction in young and middle-aged populations

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097944
Enrollment
Unknown
Registered
2025-02-27
Start date
2025-02-27
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction with Acute ST-segment Elevation

Interventions

Acute ST-elevation myocardial infarction group:None
Non-acute ST-elevation myocardial infarction group:None

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-60 years old. (2) Coronary angiography has been perfected. (3) Patients with acute ST-elevation myocardial infarction who are initially diagnosed meet the guidelines formulated by the Cardiovascular Disease Branch of the Chinese Medical Association. (4) The diagnosis of coronary heart disease is consistent with: coronary angiography shows that the degree of stenosis of any coronary artery and its main branches is >=50%.

Exclusion criteria

Exclusion criteria: (1) There is non-obstructive acute myocardial infarction such as coronary muscle bridging and coronary spasm. (2) History of old myocardial infarction, coronary artery bypass transplantation, coronary intervention, and other structural heart disease. (3) Combined with malignant arrhythmia, liver and kidney insufficiency, tumor, connective tissue disease, blood disease, trauma, tuberculosis, etc. (4) Patients with emotional and mental disorders, and those with depression are unable to cooperate with the progress of research.

Design outcomes

Primary

MeasureTime frame
Blood cell composition;

Secondary

MeasureTime frame
Blood biochemistry;

Countries

China

Contacts

Public ContactZhang Jing

Northern Jiangsu People's Hospital

zhangjingyjs@163.com+86 159 5273 9006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026